Navigation Links
Blood Thinning Medication Could Prevent Strokes

Anticoagulation therapy is used to treat deep vein thrombosis, which is a blood clot in veins of the legs, pelvis or arms. Researchers say several new studies show the medication ximelagatran (Exanta), could simplify anticoagulation therapy.//

In the first study, researchers studied DVT( Deep vein thrombosis) patients and compared the effectiveness and safety of ximelagatran compared to standard treatment with the anticoagulants enoxaparin (Lovenox) and warfarin (Coumadin). Current therapy for patients with acute venous thromboembolism consists of about a week of the anticoagulant heparin (Calciparine or Liquaemin) overlapped with and followed by long-term, oral anticoagulation therapy such as warfarin. Warfarin is given orally but is associated with unpredictable responses, and continued monitoring and adjustments are therefore necessary. Researchers found ximelagatran was as effective as enoxaparin/warfarin without the need for coagulation monitoring or dose adjustment.

In another study, researchers studied the effectiveness of ximelagatran compared to warfarin for prevention of strokes in patients with atrial fibrillation.It was found that the primary event rate for strokes associated with ximelagatran was 1.6 percent per year and with warfarin was 1.2 percent per year and there was no major difference between treatment groups in rates of major bleeding, but total bleeding was lower with ximelagatran.
'"/>




Page: 1

Related medicine news :

1. Recommendations for Treatment of Blood Pressue
2. Blood Cells Capable of Regenerating Liver
3. Blood clots likely in long travel
4. Hemochromatosis Patients Blood is Safe
5. Blood transfusions beneficial after heart attacks
6. Blood Pressure Drug may slow wasting in burn victims
7. Levels Of Blood Proteins May Help Heart Disease Care
8. Blood test may identify ovarian cancer
9. A Blood test for suicide risk?
10. Blood Pressure Drugs maintain muscle strength
11. Blood test diagnoses heart failure in short time
Post Your Comments:
(Date:10/13/2008)...levels were lower than Alzheimer,s patients, healt...hDay News) -- Parkinson,s disease patients are mor...ts to have vitamin D deficiency, say researchers f...anta. , They compared vitamin D levels in 100 P...99 healthy people matched for age and other factor...
(Date:10/13/2008)...as a greater effect on women, study found , ... alcohol you drink, the more your brain shrinks, a... is that, if you drink a lot, you,re going to hurt...ofessor of neuroscience and experimental therapeut...lege of Medicine. "This is something we knew, but ...
(Date:10/13/2008)...Oct. 13, 2008 /PRNewswire/ -- The AMERIGROUP Found... the School for Children with,Hidden Intelligence ...aining program., SCHI is a state-approved, privat...capped, underprivileged children with special need...d alleviate the suffering of the,most vulnerable m...
(Date:10/13/2008)...xercises to Build and Maintain a Healthy Spine, P...to educate people,about spine health, Texas Back I... of these nine easy exercises coincides with Natio... Spine Health Day was established to bring attenti... effective means of reducing the,prevalence and se...
Breaking Medicine News(10 mins):Health News:Parkinson's Patients More Prone to Vitamin D Deficiency 2Health News:Excess Drinking Shrinks the Brain 2Health News:AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence 2Health News:Texas Back Institute Announces 'Nine for Your Spine' for National Spine Health Day - October 16 2Health News:Texas Back Institute Announces 'Nine for Your Spine' for National Spine Health Day - October 16 3
...ning a deal to acquire the 51.5 per cent stake in ...ker Abbott Laboratories Inc. An industry source wh...reach an agreement in the next few days to buy the.../ "If all goes well, senior Abbott officials fro...
...urring substance with many health benefits or a de...B -- gamma hydroxy butyric acid -- hailed as a won...as been blamed as an illegal killer for the past 1...nd emergency room visits, while others claim its u...
... help to reduce the symptoms of pre-menstrual synd...ods to just four a year. US researchers have almos... a combination of two commonly used hormones alrea...al contraceptives. Women have to take it for 84 co...
... to prevent heart attacks, but the little white pi... new study says aspirin and related painkillers ma... to potentially deadly infections in people with A...presence of the microbe, called human cytomegalovi...
Other Medicine News:
(Date:10/9/2008)...ncreased Sales and Marketing Efforts to Accelerate...ystem, MENLO PARK, Calif., Oct. 9 /-...vices for the percutaneous repair of cardiac valve...team with the appointment of,Sean Cleary as senior...nd,Chris Richardson, as vice president of sales., ...
(Date:10/9/2008)... /- Diamyd Medical reports,... the New England Journal,of Medicine, has publishe...,of the Diamyd(R) diabetes vaccine for type 1 diab...h/20080314/297194 ), The article is now availabl...) and will be in print on October 30. It presents ...
(Date:10/8/2008)...ay Inform Treatments for Spinal Cord, Other Nerve,...wswire/ -- A protein that enables,nerve cells to c...trolling,the developing nervous system. Research i...form among nerve cells may provide a basis for eve...to their nervous system,including spinal cord inj...
(Date:10/8/2008)... Food Scientists Expand Testing Using Cellular ...RTLAND, Maine, Oct. 8 /- Wild Blueber...lease of results from a new study,showing Wild Blu...med,fruits like apples, bananas, red grapes and st...Antioxidant Activity (CAA) assay. New research,pub...
Breaking Medicine Technology:Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 1MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 2MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 3MiddleBrook Pharmaceuticals to Raise 2421 Million Through Private Placement of Common Equity 10102 4Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 1Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 2Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 3Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 4Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 5Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 6Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 7Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 8Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 9Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 10Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 11Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 12Kensey Nash Reports Second Quarter EPS of 240 21 and Revenue of 2419 6 Million 10099 13Digirad to Introduce New Clinical Standard for Cardiac SPECT 10098 1Digirad to Introduce New Clinical Standard for Cardiac SPECT 10098 2Digirad to Introduce New Clinical Standard for Cardiac SPECT 10098 3Come Home to Kansas Announced by KTEC 2732 1Come Home to Kansas Announced by KTEC 2732 2
...iion Therapeutics,Inc. today announced that its r...University, have discovered a ,minicell, vaccine,d...st several,disease-causing infections., These find...f,the journal, Vaccine, and the paper was publishe...ines contain live micro-organisms, the ,minicell,...
...educed the number of,new or enlarged lesions compa...ion at upcoming medical meeting -, CAMBRIDGE, Mass...FirstCall/ -- Biogen Idec, Inc. and PDL BioPharma,...E trial, a Phase 2,randomized, double-blind, plac...y endpoint in relapsing multiple sclerosis (MS),pa...
Other Medicine Technology:Vaxiion Researchers Discover Novel Vaccine Delivery System in,Collaboration with San Diego State University 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 2Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 3Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 4Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients,With Relapsing Multiple Sclerosis 5
The Focus Diagnostics Rickettsia Indirect Immunofluorescence Antibody (IFA) IgM test is intended for the detection and semi-quantitation of human IgM class antibodies to Spotted Fever and Typhus Feve
...est Kits for the detection and semi-quantitation o... burnetii. Our dual antigen-spot slide wells allow...differentiation of antibodies to C. burnetii Phase...ses, Focus Diagnostics' Q Fever IFA Test Kits can ...
Indirect immunofluorescent antibody (IFA) test for the detection and semi-quantitation of human serum IgG antibodies to Epstein-Barr viral capsid antigen (VCA). Each kit contains ten 12-well slides,
CMF OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, exclu
Medicine Products: